SpectraScience Updates Expected SEC Filing Dates
April 24 2014 - 9:15AM
Marketwired
SpectraScience Updates Expected SEC Filing Dates
SAN DIEGO, CA--(Marketwired - Apr 24, 2014) - SpectraScience,
Inc. (OTCQB: SCIE) announced today that the Company filed its Form
10Q for the period ended September 30, 2013 on April 18, 2014 and
plans to file its late filings with the Securities and Exchange
Commission in accordance with the following schedule:
| |
|
|
|
| Period Ended |
|
Expected Filing Date |
|
|
|
10K December 31, 2013 |
|
May 28, 2014 |
|
|
|
10Q March 31, 2014 |
|
June 16, 2014 |
|
| |
|
|
|
In order to prevent inadvertent disclosure while catching up on
filings, the next investor update call will be scheduled after the
company is once again current in its submissions. It is
expected the next business update conference call will be scheduled
for late June.
About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that
designs, develops, manufactures and markets light-based analysis
systems capable of determining whether tissue is normal,
pre-cancerous or cancerous without physically removing tissue from
the body. The WavSTAT® Optical Biopsy System uses light to
optically diagnose tissue and provide the physician with an
immediate analysis. With approval for sale under the CE Mark for
the European Union, the WavSTAT System is the first commercially
available product that incorporates this innovative technology for
clinical use.
For more information:
Visit our web site www.spectrascience.com
Forward-Looking Statement for SpectraScience, Inc.
This news release contains forward-looking statements that
involve risks and uncertainties that may cause SpectraScience's
actual results to differ materially from results discussed in
forward-looking statements. Readers are urged to carefully review
and consider the various disclosures made by SpectraScience in this
news release, its most recent Form 10-K and in SpectraScience's
other reports filed with the Securities and Exchange Commission
("SEC") that attempt to advise interested parties of the risks and
factors that may affect SpectraScience's business. These
forward-looking statements are qualified in their entirety by the
cautions and risk factors filed by SpectraScience in its annual
report on Form 10-K and other documents.
Contacts: Media and Investors: SpectraScience, Inc. Lowell
Giffhorn CFO Phone: (858) 847-0200 x2019 Email: Email Contact
SpectraScience (CE) (USOTC:SCIE)
Historical Stock Chart
From Oct 2024 to Nov 2024
SpectraScience (CE) (USOTC:SCIE)
Historical Stock Chart
From Nov 2023 to Nov 2024
